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The IA will be fit for purpose, provided the Department addresses the points set out in 
this opinion.  
 
While the IA describes the likely costs and benefits associated with the measure, the 
Department should provide a fuller discussion of a number of the costs, along with 
some indication of their likely extent where possible. This would allow for a more 
meaningful consultation about these costs. 
 
The IA would also benefit from a fuller description of the EU Tobacco Products 
Directive within the body of the text. This would allow readers to understand better 
where the proposed measure goes beyond the Directive. 
 
Background (extracts from IA) 
 
What is the problem under consideration? Why is government intervention 
necessary? 
 
”Tobacco use remains one of the most significant challenges to public health across 
the United Kingdom and is the leading cause of premature death in the UK. The 
Government remains concerned about the take up of smoking by young people, the 
difficulty that adult smokers can have in quitting smoking and the consequences for 
the health of others from exposure to second hand smoke (SHS). Research evidence 
suggests that standardised packaging of tobacco products can reduce the appeal of 
tobacco products, increase the effectiveness of health warnings on tobacco 
packages and reduce the ability of tobacco packages to mislead consumers about 
the harmful effects of smoking. It could also address the contribution smoking makes 
to the sustaining of socioeconomic health inequalities."  
 
What are the policy objectives and the intended effects? 
 
“The objectives of standardised tobacco packaging would be to improve public health 
by discouraging young people from taking up smoking, supporting quitting among 
smokers who want to quit and helping people who have quit to avoid relapse back to 
smoking. Achieving these aims will improve the health of those who never start to 
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smoke and those who succeed in quitting smoking.” 
 
What policy options have been considered, including any alternatives to 
regulation? 
 
“Option 1: Require changes to legislation to bring the UK in line with the European 
Tobacco Products Directive in 2016. (This is essentially a “do nothing” option). 
 
Option 2: Go beyond the European Tobacco Products Directive in 2016 and require 
standardised tobacco packaging of cigarettes and hand rolling tobacco (HRT). In line 
with the approach set out in the consultation document, this would involve the 
standardisation of pack colour and shape and the removal of all branding except brand 
name in a standardised typeface. Relevant legal markings such as health warnings and 
tax stamps would be retained as well as authentication markings to reduce trade in 
illegal tobacco products.  
 
Option 3: Defer a decision pending collection of evidence on experience with plain 
packaging in Australia. 
 
Option 2 is preferred in view of the possibility of very substantial health gains that it 
offers, deferral of which would be permanently detrimental to successive cohorts of 
young people and would-be quitters.” 
 
Identification of costs and benefits, and the impacts on business, civil society 
organisations, the public sector and individuals, and reflection of these in the 
choice of options 
 
The proposal is to standardise tobacco packaging as part of the aim of improving 
public health. The analysis within the IA provides a full assessment of the wider 
health benefits associated with the measure. These have been monetised as far as 
possible and included in the overall NPV. 
 
In terms of the specific impact on business, the analysis indicates that this measure 
will affect business through transition costs resulting from the de-branding to 
standardisation of packaging; reduced profits from any resulting reduction in demand 
for the products; and, in the longer term, lower production costs associated with 
standardised packs.  
 
The IA provides a commentary on those costs and benefits included in the business 
NPV. In order to ensure a more effective consultation, the Department should 
address the following areas prior to publication:  
 
 Description of standardised packaging: The IA provides a description of the 
standardised packaging of tobacco, referring to the “standardised shape, size and 
materials” (paragraph 76). However, given the lack of breakdown of transition 
costs (see below), it is not clear that the costs take account of any 
disproportionate impact of a proposed size of packet on certain cigarette 
manufacturers. Tobacco manufacturers who manufacture large/small/slim 
cigarettes will need to adapt to the standard sized pack to meet their needs. The 
IA should provide a discussion and indicate the likely level of costs associated 
with this. 
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 Impact on manufacturing: The IA explains how, in meeting the requirements of the 
proposal, there may be “initial resource costs to manufacturers within the wider 
tobacco industry to achieve compliance”. In particular, the IA discusses how 
current manufacturers’ existing capital equipment may not be compatible with, or 
possibly inefficient, in producing standardised packaging (paragraph 92). The 
associated transition costs, (paragraphs 92 to 96), will need to be confirmed 
during consultation. Also, the IA does not discuss sufficiently the impact of the 
requirements on the manufacturing companies and their employees, and which 
impacts should be considered direct or indirect. The IA should provide a 
discussion of the impact on those companies involved in the packaging and 
branding of tobacco and clarify which costs are direct and which indirect. 
 
 Disposal costs: Paragraph 99 indicates that there are potential costs associated 
with the disposal of duty paid and currently branded packs (on which duty has 
already been paid) in the transition to standardised packaging. No quantification 
of these costs has been provided at this stage. The IA should include indicative 
costs, perhaps based on scenario analysis of the potential phasing of the 
measure, in order to aid meaningful consultation.  
 
 Net Present Value: The IA records a large positive NPV that reflects mainly the 
health benefits of the proposal. The IA categorises the costs and benefits and 
includes a brief explanation of the loss of brand value (paragraph 84). However, it 
is not clear whether any lost profits are accounted for within the NPV. The IA 
should be clearer on this point and include a summary table of the costs and 
benefits included in both the NPV and business NPV.  
 
 Options: The Department explains that its preferred option will go beyond the EU 
Tobacco Products Directive, which constitutes the baseline for this assessment. 
The requirements of the Directive are provided at Annex E of the IA. The 
Department should provide details of the Directive within the body of the IA, to 
allow a comparison to be made between it and the options. 
 
 Transition Costs: While the IA briefly explains the transition costs (paragraph 88), 
it should provide the composition of these costs, for clarity, in a summary table. 
 
In addition to the above points, the Department should use the consultation to 
strengthen the following points before submission of a final stage IA: 
 
 Reduction in retail transaction costs: The IA explains that, following research, the 
Department estimates a cost saving to retailers and customers of 1.5 second’s 
time per transaction. This results from a quicker response time in selecting and 
serving a standardised tobacco pack (paragraphs 102 to 109). The IA includes a 
discussion of empirical testing of the time taken to serve customers where 
tobacco is in standardised packaging. The discussion and the conclusions should 
be tested during consultation and the results reported in the final IA. 
 
 Packaging costs. The IA contends that standardised packaging will be 
"substantially cheaper to produce" (paragraph 95). This should be examined 
during consultation and the results of the consultation included in the IA at final 
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stage to substantiate the claim. 
 
 Tobacco Products Directive: The IA states that “where manufacturers are 
expected to incur set up costs in order to reconfigure equipment in light of the 
Directive, the incremental cost of standardised packaging over and above this 
could be close to zero” (paragraph 98). The IA should seek to gather evidence at 
consultation to confirm this statement. 
 
 Direct/indirect costs. The IA discusses the loss of profit due to the reduced 
consumption of cigarettes as being indirect and therefore out of scope of OITO 
(paragraph 170). The IA would benefit at final stage from a clarification between 
direct and indirect costs.  
 
Comments on the robustness of the Small & Micro Business Assessment 
(SaMBA) 
 
The proposals increase the scope of regulation on business. Therefore a SaMBA is 
required.  
 
The SaMBA is sufficient for this stage of policy development. The IA assesses how 
the proposals will affect micro and small businesses within the retail sector (page 48). 
The key impacts include a reduction in retail transaction costs and reduced profits 
from tobacco sales. The final stage SaMBA should provide additional analysis, based 
on the evidence gathered, and covering all potential small and micro businesses, in 
all potential sectors affected e.g. any small or micro businesses in the supply chain 
for the manufacture or branding of tobacco packaging. 
 
We note that the Department will use the consultation to investigate potential means 
to mitigate any impacts on small and micro businesses (paragraph 198).  
 
Comments on the robustness of the OITO assessment. 
 
The baseline for calculations of benefits and costs from the proposal is the prior or 
simultaneous implementation of the European Tobacco Products Directive in 2016. A 
separate IA will need to be published to cover the changes under that Directive. 
 
As noted above, the preferred option is to go beyond the European Tobacco 
Products Directive and require standardised tobacco packaging of cigarettes and 
hand rolling tobacco. By going beyond minimum EU requirements, the Department is 
gold-plating the measure. 
 
In recognition of this, the IA says that this is a regulatory proposal which is in scope 
of OITO and would have a net benefit to business (an ‘IN’ with ‘Zero Net Cost’). The 
OITO position depends on which costs are classed as direct and which indirect. The 
Department's assessment assumes that transitional costs to businesses from 
redesigning packaging are direct, as are the savings from reduced packaging in the 
long run, while costs from loss of profit and loss of brand are indirect. At final stage, 
the Department will need to provide further evidence to support its OITO assessment 
and its classification of costs as direct and indirect, in order for the RPC to validate 
the equivalent annual net cost to business. 
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In the OITO section of the IA (page 42), it would be helpful to summarise the 
quantified costs and benefits. In summary, the Department should strengthen 
evidence supporting the equivalent annual net cost to business, so that the RPC can 
validate the estimate at final stage. 
 
Signed 
 
Michael Gibbons, Chairman 
 
